E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers W > Headlines for Warner-Chilcott Ltd. > News item
Published on 2/22/2007 in the Prospect News Special Situations Daily.

ValueAct ups stake in Warner Chilcott

By Lisa Kerner

Charlotte, N.C., Feb. 22 - Warner Chilcott Ltd. investor ValueAct Capital Master Fund LP and its affiliates increased their stake in the company with the purchase of 3,864,861 shares of common stock for approximately $55.6 million, according to a schedule 13D filing with the Securities and Exchange Commission.

ValueAct is now the beneficial owner of 13,585,421 shares, or 5.5%, of the Rockaway, N.J., specialty pharmaceutical company's outstanding shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.